Pain associated with aminolevulinic acid-photodynamic therapy of skin disease

Journal of the American Academy of Dermatology

Volumn 61, Issue 6, 2009, Pages 1033-1043

  Warren, Christine B ^a   Karai, Laszlo J ^b   Vidimos, Allison ^b   Maytin, Edward V ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

aminolevulinic acid; anesthesia; methyl aminolevulinic acid; pain; photodynamic therapy; substance P; vanilloid receptor

Indexed keywords

ADRENALIN; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ANESTHETIC AGENT; ANTIPAIN; EMLA; IDEA 070; LIDOCAINE; UNCLASSIFIED DRUG;

ACNE VULGARIS; ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CHEMOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COOLING; DRUG INHIBITION; DRUG TARGETING; DRUG WITHDRAWAL; HUMAN; LIGHT EMITTING DIODE; MELANOMA; NOCICEPTION; PAIN; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROPHYLAXIS; PSORIASIS; REVIEW; SKIN CANCER; SKIN DEFECT; SKIN DISEASE; SKIN SURFACE; TEMPERATURE MEASUREMENT; VERRUCA VULGARIS;

ADMINISTRATION, CUTANEOUS; AMINOLEVULINIC ACID; ANALGESIA; HUMANS; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RADIOTHERAPY DOSAGE;

EID: 71549138675     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.03.048     Document Type: Review

References (80)

1. Hasan T., Ortel B., Solban N., and Pogue B. Photodynamic therapy of cancer. In: Kufe D.W., Frei E., Holland J.F., Weichselbaum R.R., Pollack R.E., Bast Jr. R.C., et al. (Eds). Cancer medicine. 7th ed (2006), BC Decker Inc, Hamilton, Ontario, Canada 537-548
2. Thunell S., Harper P., and Brun A. Porphyrins, porphyrin metabolism and porphyrias, IV: pathophysiology of erythropoietic protoporphyria-diagnosis, care and monitoring of the patient. Scand J Clin Lab Invest 60 (2000) 581-604
3. Wennberg A.M. Pain, pain relief and other practical issues in photodynamic therapy. Australas J Dermatol 46 Suppl (2005) S3-S4 discussion S23-5
4. Grapengiesser S., Ericson M., Gudmundsson F., Larko O., Rosen A., and Wennberg A.M. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 27 (2002) 493-497
5. Clark C., Bryden A., Dawe R., Moseley H., Ferguson J., and Ibbotson S.H. Topical 5-aminolevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19 (2003) 134-141
6. Kuijpers D.I., Thissen M.R., Thissen C.A., and Neumann M.H. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 5 (2006) 642-645
7. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
8. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21 (1998) 531-543
9. Waldmann R., Champigny G., Bassilana F., Heurteaux C., and Lazdunski M. A proton-gated cation channel involved in acid-sensing. Nature 386 (1997) 173-177
10. Kasche A., Luderschmidt S., Ring J., and Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 5 (2006) 353-356
11. Moloney F.J., and Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolevulinic acid methylester with topical 5-aminolevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 157 (2007) 87-91
12. Wiegell S.R., Stender I.M., Na R., and Wulf H.C. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 139 (2003) 1173-1177
13. Wiegell S.R., and Wulf H.C. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol 54 (2006) 647-651
14. Juzeniene A., Juzenas P., Ma L.W., Iani V., and Moan J. Topical application of 5-aminolevulinic acid, methyl 5-aminolevulinate and hexyl 5-aminolevulinate on normal human skin. Br J Dermatol 155 (2006) 791-799
15. Wiegell S.R., Skiveren J., Philipsen P.A., and Wulf H.C. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 158 (2008) 727-733
16. Kleinpenning M.M., Smits T., Ewalds E., van Erp P.E., van de Kerkhof P.C., and Gerritsen M.J. Heterogeneity of fluorescence in psoriasis after application of 5-aminolevulinic acid: an immunohistochemical study. Br J Dermatol 155 (2006) 539-545
17. Zhou X., Pogue B.W., Chen B., Demidenko E., Joshi R., Hoopes J., et al. Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int J Radiat Oncol Biol Phys 64 (2006) 1211-1220
18. Radakovic-Fijan S., Blecha-Thalhammer U., Schleyer V., Szeimies R.M., Zwingers T., Honigsmann H., et al. Topical aminolevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 152 (2005) 279-283
19. Fritsch C., Stege H., Saalmann G., Goerz G., Ruzicka T., and Krutmann J. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed 13 (1997) 181-185
20. Stender I.M., Na R., Fogh H., Gluud C., and Wulf H.C. Photodynamic therapy with 5-aminolevulinic acid or placebo for recalcitrant foot and hand warts: randomized double-blind trial. Lancet 355 (2000) 963-966
21. Wang Y.S., Tay Y.K., Kwok C., and Tan E. Photodynamic therapy with 20% aminolevulinic acid for the treatment of recalcitrant viral warts in an Asian population. Int J Dermatol 46 (2007) 1180-1184
22. Papageorgiou P., Katsambas A., and Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 142 (2000) 973-978
23. Akaraphanth R., Kanjanawanitchkul W., and Gritiyarangsan P. Efficacy of ALA-PDT vs blue light in the treatment of acne. Photodermatol Photoimmunol Photomed 23 (2007) 186-190
24. Hongcharu W., Taylor C.R., Chang Y., Aghassi D., Suthamjariya K., and Anderson R.R. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 115 (2000) 183-192
25. Wiegell S.R., and Wulf H.C. Photodynamic therapy of acne vulgaris using methyl aminolevulinate: a blinded, randomized, controlled trial. Br J Dermatol 154 (2006) 969-976
26. Horfelt C., Funk J., Frohm-Nilsson M., Wiegleb Edstrom D., and Wennberg A.M. Topical methyl aminolevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol 155 (2006) 608-613
27. Schleyer V., Radakovic-Fijan S., Karrer S., Zwingers T., Tanew A., Landthaler M., et al. Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolevulinic acid in psoriasis: a randomized, double-blind phase I/II study. J Eur Acad Dermatol Venereol 20 (2006) 823-828
28. Fransson J., and Ros A.M. Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed 21 (2005) 326-332
29. Beattie P.E., Dawe R.S., Ferguson J., and Ibbotson S.H. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol 29 (2004) 560-562
30. Radakovic-Fijan S., Blecha-Thalhammer U., Kittler H., Honigsmann H., and Tanew A. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol 53 (2005) 823-827
31. Horfelt C., Stenquist B., Larko O., Faergemann J., and Wennberg A.M. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action. Acta Derm Venereol 87 (2007) 325-329
32. Ericson M.B., Sandberg C., Stenquist B., Gudmundson F., Karlsson M., Ros A.M., et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 151 (2004) 1204-1212
33. Salim A., Leman J.A., McColl J.H., Chapman R., and Morton C.A. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 148 (2003) 539-543
34. Piacquadio D.J., Chen D.M., Farber H.F., Fowler Jr. J.F., Glazer S.D., Goodman J.J., et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 140 (2004) 41-46
35. Cottrell W.J., Paquette A.D., Keymel K.R., Foster T.H., and Oseroff A.R. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 14 (2008) 4475-4483
36. Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol 24 (2006) 16-25
37. Morton C.A., Whitehurst C., Moore J.V., and MacKie R.M. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 143 (2000) 767-772
38. Touma D., Yaar M., Whitehead S., Konnikov N., and Gilchrest B.A. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 140 (2004) 33-40
39. Babilas P., Knobler R., Hummel S., Gottschaller C., Maisch T., Koller M., et al. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol 157 (2007) 111-117
40. Wang I., Bendsoe N., Klinteberg C.A., Enejder A.M., Andersson-Engels S., Svanberg S., et al. Photodynamic therapy vs cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144 (2001) 832-840
41. Alexiades-Armenakas M.R., and Geronemus R.G. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 139 (2003) 1313-1320
42. Alexiades-Armenakas M.R., and Geronemus R.G. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol 3 (2004) 548-551
43. Babilas P., Travnik R., Werner A., Landthaler M., and Szeimies R.M. Split-face-study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Ges 6 (2008) 25-32
44. Babilas P., Kohl E., Maisch T., Backer H., Gross B., Branzan A.L., et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 154 (2006) 712-718
45. Wiegell S.R., Haedersdal M., Philipsen P.A., Eriksen P., Enk C.D., and Wulf H.C. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 158 (2008) 740-746
46. Haedersdal M., Togsverd-Bo K., Wiegell S.R., and Wulf H.C. Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: a randomized controlled trial. J Am Acad Dermatol 58 (2008) 387-394
47. Palsson S., Gustafsson L., Bendsoe N., Soto Thompson M., Andersson-Engels S., and Svanberg K. Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolevulinic acid. Br J Dermatol 148 (2003) 1179-1188
48. Svaasand L.O. Photodynamic and photohyperthermic response of malignant tumors. Med Phys 12 (1985) 455-461
49. Warloe T., Peng Q., and Moan J. Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid. In: Spinelli P., Dal Fante M., and Marchesini R. (Eds). Photodynamic therapy and biomedical lasers (1992), Elsevier Science Publishers BV, Amsterdam p. 449-53
50. Maytin E.V., Wimberly J.M., and Anderson R.R. Thermotolerance and the heat shock response in normal human keratinocytes in culture. J Invest Dermatol 95 (1990) 635-642
51. Maytin E.V., Wimberly J.M., and Kane K.S. Heat shock modulates UVB-induced cell death in human epidermal keratinocytes: evidence for a hyperthermia-inducible protective response. J Invest Dermatol 103 (1994) 547-553
52. Mandadi S., Tominaga T., Numazaki M., Murayama N., Saito N., Armati P.J., et al. Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCepsilon-mediated phosphorylation at S800. Pain 123 (2006) 106-116
53. Numazaki M., and Tominaga M. Nociception and TRP channels. Curr Drug Targets CNS Neurol Disord 3 (2004) 479-485
54. Zhang H., Cang C.L., Kawasaki Y., Liang L.L., Zhang Y.Q., Ji R.R., et al. Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia. J Neurosci 27 (2007) 12067-12077
55. Olah Z., Karai L., and Iadarola M.J. Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem 276 (2001) 31163-31170
56. Shin J., Cho H., Hwang S.W., Jung J., Shin C.Y., Lee S.Y., et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci U S A 99 (2002) 10150-10155
57. Siddall P.J., and Cousins M.J. Neurobiology of pain. Int Anesthesiol Clin 35 (1997) 1-26
58. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
59. Glover R.A., Bailey C.S., Barrett K.E., Wasserman S.I., and Gigli I. Histamine release from rodent and human mast cells induced by protoporphyrin and ultraviolet light: studies of the mechanism of mast-cell activation in erythropoietic protoporphyria. Br J Dermatol 122 (1990) 501-512
60. Lim H.W., Gigli I., and Wasserman S.I. Differential effects of protoporphyrin and uroporphyrin on murine mast cells. J Invest Dermatol 88 (1987) 281-286
61. Rud E., Gederaas O., Hogset A., and Berg K. 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 71 (2000) 640-647
62. Huang W., and Vidimos A. Topical anesthetics in dermatology. J Am Acad Dermatol 43 (2000) 286-298
63. Langan S.M., and Collins P. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anesthesia with a eutectic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 154 (2006) 146-149
64. Holmes M.V., Dawe R.S., Ferguson J., and Ibbotson S.H. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 150 (2004) 337-340
65. Skiveren J., Haedersdal M., Philipsen P.A., Wiegell S.R., and Wulf H.C. Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta Derm Venereol 86 (2006) 409-411
66. Sandberg C., Stenquist B., Rosdahl I., Ros A.M., Synnerstad I., Karlsson M., et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 86 (2006) 404-408
67. Nolano M., Simone D.A., Wendelschafer-Crabb G., Johnson T., Hazen E., and Kennedy W.R. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 81 (1999) 135-145
68. Halldin C.B., Paoli J., Sandberg C., Ericson M.B., and Wennberg A.M. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses. Acta Derm Venereol 88 (2008) 311-313
69. Berking C., Herzinger T., Flaig M.J., Brenner M., Borelli C., and Degitz K. The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients. Dermatol Surg 33 (2007) 825-830
70. Borelli C., Herzinger T., Merk K., Berking C., Kunte C., Plewig G., et al. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg 33 (2007) 314-318
71. Paoli J., Halldin C., Ericson M.B., and Wennberg A.M. Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol 33 (2008) 559-564
72. Pagliaro J., Elliott T., Bulsara M., King C., and Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment; a pilot study. Dermatol Surg 30 (2004) 63-66
73. Stender I.M., Borgbjerg F.M., Villumsen J., Lock-Andersen J., and Wulf H.C. Pain induced by photodynamic therapy of warts. Photodermatol Photoimmunol Photomed 22 (2006) 304-309
74. Goldman M.P., Merial-Kieny C., Nocera T., and Mery S. Comparative benefit of two thermal spring waters after photodynamic therapy procedure. J Cosmet Dermatol 6 (2007) 31-35
75. Leff D.R., Nortley M., Dang V., and Bhutiani R.P. The effect of local cooling on pain perception during infiltration of local anesthetic agents, a prospective randomized controlled trial. Anaesthesia 62 (2007) 677-682
76. Voets T., Droogmans G., Wissenbach U., Janssens A., Flockerzi V., and Nilius B. The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature 430 (2004) 748-754
77. Bautista D.M., Siemens J., Glazer J.M., Tsuruda P.R., Basbaum A.I., Stucky C.L., et al. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 448 (2007) 204-208
78. Colburn R.W., Lubin M.L., Stone Jr. D.J., Wang Y., Lawrence D., D'Andrea M.R., et al. Attenuated cold sensitivity in TRPM8 null mice. Neuron 54 (2007) 379-386
79. Dhaka A., Murray A.N., Mathur J., Earley T.J., Petrus M.J., and Patapoutian A. TRPM8 is required for cold sensation in mice. Neuron 54 (2007) 371-378
80. Proudfoot C.J., Garry E.M., Cottrell D.F., Rosie R., Anderson H., Robertson D.C., et al. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr Biol 16 (2006) 1591-1605